Online Exporter Rapid Test Antigen Kit - EZER Flu&Covid-19 Antigen Duo rapid test – Genesis
Online Exporter Rapid Test Antigen Kit - EZER Flu&Covid-19 Antigen Duo rapid test – Genesis Detail:
Introduction
Clinical signs and symptoms of respiratory viral infection due to SARS-CoV-2 and influenza can be similar. SARSCoV-2, influenza A and influenza B viral antigens are generally detectable in upper respiratory specimens during the acute phase of infection.
Influenza virus belongs to the family of Orthomyxoviridae, and immunologically diverse, single-stranded RNA viruses. There influenza A and B virus is the main pathogen that severe illnesses both in human and in many animal species. Based on the current epidemiological investigation, the incubation period is 1 to 4 days. The main manifestations include acute fever, general aching and respiratory symptoms. Both Type A and B viruses can circulate simultaneously, but usually one type is dominant during a given season.1
COVID-19 is an acute respiratory infectious disease. People are generally susceptible. Currently, the patients infected by the novel coronavirus are the main source of infection; asymptomatic infected people can also be an infectious source. Based on the current epidemiological investigation, the incubation period is 1 to 14 days, mostly 3 to 7 days. The main manifestations include fever, fatigue and dry cough. Nasal congestion, runny nose, sore throat, myalgia and diarrhea are found in a few cases.
EZERTM Flu & COVID-19 Antigen Duo Rapid Test is intended for the simultaneous qualitative detection and differentiation of the nucleocapsid protein antigens from SARS-CoV-2, influenza A and influenza B in direct nasopharyngeal (NP) specimens. The detection is based on the antibodies which were developed specifically recognizing and reacting with the nucleoprotein of virus.
Detection
EZERTM Flu & COVID-19 Antigen Duo Rapid Test is the simultaneous qualitative detection and differentiation of the nucleocapsid protein antigens from SARS-CoV-2, influenza A and influenza B in direct nasopharyngeal (NP) specimens.
Specimen
Nasopharyngeal
Limit of Detection (LoD)
2019 Novel Coronavirus: 74.8 TCID50/mL
Influenza A
| Influenza Viral Strain |
Calculated |
| A/New Caledonia/20/1999_H1N1 |
8.50×103 |
| A/California/04/2009_H1N1 |
2.11×103 |
| A/PR/8/34_H1N1 |
2.93×103 |
| A/Bean Goose/Hubei/chenhu XVI35-1/2016_H3N2 |
4.94×102 |
| A/Guizhou/54/89_H3N2 |
3.95×102 |
| A/Human/Hubei/3/2005_H3N2 |
2.93×104 |
| A/Bar-headed Goose/QH/BTY2/2015_H5N1 |
1.98×105 |
| A/Anhui/1/2013_H7N9 |
7.90×105 |
Influenza B.
| Influenza Viral Strain |
Calculated |
| B/Victoria |
4.25×103 |
| B/Yamagata |
1.58×102 |
Accuracy
Influenza A
Relative Sensitivity : 86.8%
Relative Specificity: 94%
Accuracy: 92.2%
Influenza B
Relative Sensitivity: 91.7%
Relative Specificity: 97.5%
Accuracy: 96.1%
COVID-19
Relative Sensitivity: 96.6%
Relative Specificity: 100%
Accuracy: 98.9%
Time to results
Read results at 15minutes and no more than 30 minutes.
Kit storage conditions
2~30°C.
Contents
| Test devices | 20 tests |
| Sterilized swabs | 20 pcs |
| Extraction tubes (with 0.5mL extraction | 20 pcs |
| buffer) | 20 pcs |
| Nozzle with filter | 1 pcs |
| Tube Stand | 1 pcs |
Ordering Information
|
Product |
Cat.No. |
Contents |
|
EZERTM Flu & COVID-19 Antigen Duo |
P211137 |
20 Tests |
Product detail pictures:
Related Product Guide:
Our company since its inception, always regards product quality as enterprise life, continuously improve production technology, improve product quality and continuously strengthen enterprise total quality management, in strict accordance with the national standard ISO 9001:2000 for Online Exporter Rapid Test Antigen Kit - EZER Flu&Covid-19 Antigen Duo rapid test – Genesis , The product will supply to all over the world, such as: Chile, Lesotho, Kenya, Due to our good products and services, we have received good reputation and credibility from local and international customers. If you need more information and are interested in any of our products, please feel free to contact us. We look forward to becoming your supplier in the near future.
By Lilith from Argentina - 2018.02.21 12:14
This is the first business after our company establish, products and services are very satisfying, we have a good start, we hope to cooperate continuous in the future!
By Johnny from Indonesia - 2018.09.12 17:18
